Government Regulation of Nanorobots in Medicine: How the FDA and PTO Handle These New Technologies
July/August 2018
The Journal of Robotics, Artificial Intelligence & Law
By Jessica L. Marks; Shana K. Cyr, Ph.D.
Not surprisingly, the nanorobotics industry is growing. As of 2014, there were over 200 companies pursuing commercial efforts in nanomedicine, with at least 23 in the advanced stages of development. The nanorobots market is expected to grow more than six percent each year until at least 2020, with the primary driver being their use in medicine. In this article, Finnegan attorneys Jessica Marks and Shana Cyr discuss government regulation of nanorobots.
Read the full article here.